Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Krishna Nalleballe

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
479
2.580
 Why?
Thrombolytic Therapy
4
2022
110
1.270
 Why?
Pneumonia, Viral
6
2020
170
1.260
 Why?
Fibrinolytic Agents
4
2022
126
1.260
 Why?
Coronavirus Infections
6
2020
179
1.240
 Why?
Tissue Plasminogen Activator
3
2020
110
1.220
 Why?
Pandemics
8
2020
567
0.820
 Why?
Endovascular Procedures
2
2022
179
0.820
 Why?
Cavernous Sinus
1
2022
16
0.780
 Why?
Carotid-Cavernous Sinus Fistula
1
2022
12
0.780
 Why?
Conflict of Interest
2
2020
25
0.720
 Why?
Embolization, Therapeutic
1
2022
88
0.720
 Why?
Iodine Compounds
1
2020
7
0.700
 Why?
Brain Edema
1
2020
41
0.680
 Why?
Brain Ischemia
4
2022
157
0.640
 Why?
Mucopolysaccharidosis II
1
2018
1
0.630
 Why?
Contrast Media
1
2020
186
0.630
 Why?
Cardiology
1
2020
91
0.620
 Why?
Medicare
1
2020
245
0.620
 Why?
Coronary Angiography
1
2020
353
0.610
 Why?
Physicians
1
2020
229
0.560
 Why?
Hospitalization
6
2022
665
0.490
 Why?
Databases, Factual
3
2020
660
0.420
 Why?
Humans
29
2022
50201
0.410
 Why?
Telemedicine
1
2019
467
0.410
 Why?
Headache
2
2022
76
0.360
 Why?
Aged
10
2021
9505
0.360
 Why?
Time Factors
4
2020
2909
0.350
 Why?
Autoimmune Diseases
2
2020
81
0.340
 Why?
Ischemic Attack, Transient
2
2020
56
0.330
 Why?
Immunosuppressive Agents
2
2020
226
0.320
 Why?
United States
6
2020
4898
0.300
 Why?
Female
16
2021
26829
0.280
 Why?
Male
14
2021
25572
0.270
 Why?
Arkansas
4
2019
1988
0.260
 Why?
Emergency Service, Hospital
2
2020
482
0.250
 Why?
Middle Aged
11
2021
12356
0.250
 Why?
Tomography, X-Ray Computed
2
2020
1160
0.220
 Why?
Triage
2
2021
61
0.220
 Why?
Thrombectomy
2
2020
70
0.210
 Why?
Drug Industry
2
2020
38
0.210
 Why?
Neuroimaging
2
2020
86
0.210
 Why?
Critical Care
2
2021
215
0.190
 Why?
Retrospective Studies
5
2020
6190
0.190
 Why?
Sinus Thrombosis, Intracranial
1
2021
17
0.190
 Why?
Myasthenia Gravis
1
2021
17
0.180
 Why?
Hospitalists
1
2020
11
0.180
 Why?
Intracranial Thrombosis
1
2020
16
0.180
 Why?
Ageusia
1
2020
6
0.180
 Why?
Olfaction Disorders
1
2020
7
0.180
 Why?
Neuromuscular Diseases
1
2020
30
0.180
 Why?
Health Services Misuse
1
2020
13
0.180
 Why?
Osmolar Concentration
1
2020
63
0.180
 Why?
Multiple Sclerosis
1
2020
63
0.170
 Why?
Lymphoma, Non-Hodgkin
1
2020
58
0.170
 Why?
Health Care Sector
1
2020
15
0.170
 Why?
Neurologic Examination
1
2020
76
0.170
 Why?
Infarction, Middle Cerebral Artery
1
2020
40
0.170
 Why?
Mood Disorders
1
2020
58
0.170
 Why?
Time-to-Treatment
1
2020
70
0.170
 Why?
Patient Transfer
1
2020
94
0.170
 Why?
Young Adult
2
2020
4052
0.170
 Why?
Venous Thrombosis
1
2020
88
0.170
 Why?
Brain Diseases
1
2020
80
0.170
 Why?
Subarachnoid Hemorrhage
1
2020
61
0.160
 Why?
Drug-Eluting Stents
1
2020
92
0.160
 Why?
Suicidal Ideation
1
2020
98
0.160
 Why?
Fabry Disease
1
2019
9
0.160
 Why?
Recombinant Fusion Proteins
1
2010
183
0.160
 Why?
Enzyme Replacement Therapy
1
2019
17
0.160
 Why?
Hospitals
1
2020
172
0.160
 Why?
Nervous System Diseases
1
2020
88
0.160
 Why?
Fluorocarbons
1
2019
51
0.160
 Why?
Tomography Scanners, X-Ray Computed
1
2018
12
0.160
 Why?
Angiogenesis Inhibitors
1
2010
182
0.160
 Why?
Aged, 80 and over
3
2020
3158
0.160
 Why?
Angiography, Digital Subtraction
1
2018
27
0.150
 Why?
Neuroprotective Agents
1
2019
100
0.150
 Why?
Seizures
1
2020
195
0.150
 Why?
Anxiety
1
2020
276
0.150
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
132
0.140
 Why?
Pain
1
2020
373
0.140
 Why?
Meningitis
1
2016
25
0.140
 Why?
Referral and Consultation
1
2019
284
0.140
 Why?
Diagnosis, Differential
1
2020
1041
0.140
 Why?
Myocardial Infarction
1
2020
392
0.130
 Why?
Percutaneous Coronary Intervention
1
2020
299
0.130
 Why?
Antibodies, Monoclonal
1
2010
459
0.130
 Why?
Ovarian Neoplasms
1
2010
450
0.130
 Why?
Plasma Cells
1
2016
221
0.120
 Why?
Magnetic Resonance Imaging
2
2020
1529
0.120
 Why?
Adult
5
2020
13486
0.120
 Why?
RNA-Directed DNA Polymerase
1
2002
6
0.100
 Why?
Oligodeoxyribonucleotides
1
2002
31
0.100
 Why?
DNA, Complementary
1
2002
133
0.100
 Why?
Adolescent
2
2020
6459
0.100
 Why?
Antineoplastic Agents
1
2010
1176
0.100
 Why?
Mycobacterium tuberculosis
1
2002
287
0.090
 Why?
Treatment Outcome
4
2022
5203
0.090
 Why?
Intubation, Intratracheal
2
2021
120
0.080
 Why?
Cohort Studies
2
2022
1414
0.070
 Why?
Prevalence
2
2020
960
0.070
 Why?
Risk Factors
2
2022
3644
0.050
 Why?
Intracranial Hemorrhages
1
2022
37
0.050
 Why?
Multiple Myeloma
1
2016
2934
0.050
 Why?
Cerebral Hemorrhage
1
2022
99
0.050
 Why?
Cranial Sinuses
1
2021
10
0.050
 Why?
Industry
1
2020
17
0.050
 Why?
Arthritis, Psoriatic
1
2020
9
0.050
 Why?
Spondylitis, Ankylosing
1
2020
9
0.050
 Why?
Cranial Nerves
1
2020
14
0.050
 Why?
Disease Susceptibility
1
2021
88
0.050
 Why?
Endocrine System Diseases
1
2010
10
0.040
 Why?
Colitis, Ulcerative
1
2020
52
0.040
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
22
0.040
 Why?
Mortality
1
2020
97
0.040
 Why?
Arthritis, Rheumatoid
1
2020
105
0.040
 Why?
Crohn Disease
1
2020
90
0.040
 Why?
Registries
1
2022
527
0.040
 Why?
Maximum Tolerated Dose
1
2019
40
0.040
 Why?
Administration, Oral
1
2020
432
0.040
 Why?
Tertiary Care Centers
1
2019
76
0.040
 Why?
Disease Outbreaks
1
2020
123
0.040
 Why?
alpha-Galactosidase
1
2019
9
0.040
 Why?
Administration, Intravenous
1
2019
70
0.040
 Why?
Hemorrhage
1
2020
196
0.040
 Why?
Disability Evaluation
1
2019
88
0.040
 Why?
Skin Diseases
1
2010
114
0.040
 Why?
Gastrointestinal Diseases
1
2010
128
0.040
 Why?
Electronic Health Records
1
2021
208
0.040
 Why?
Drug Administration Schedule
1
2019
369
0.040
 Why?
Recovery of Function
1
2019
188
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2010
224
0.040
 Why?
Patient Readmission
1
2019
222
0.040
 Why?
Comorbidity
1
2019
612
0.040
 Why?
Double-Blind Method
1
2019
682
0.040
 Why?
Prognosis
1
2022
1963
0.030
 Why?
Fatal Outcome
1
2016
195
0.030
 Why?
Follow-Up Studies
1
2020
2188
0.030
 Why?
Risk Assessment
1
2019
1255
0.030
 Why?
Cardiovascular Diseases
1
2010
449
0.030
 Why?
Prospective Studies
1
2020
2396
0.030
 Why?
Cross-Sectional Studies
1
2019
1580
0.030
 Why?
DNA Primers
1
2002
207
0.030
 Why?
Infant
1
2020
3584
0.020
 Why?
Child, Preschool
1
2020
3896
0.020
 Why?
Transcription, Genetic
1
2002
369
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2002
409
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2002
189
0.020
 Why?
RNA, Messenger
1
2002
1097
0.020
 Why?
Child
1
2020
6862
0.020
 Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (151) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department